CREB3L3 and fatty liver disease: While fasting (Hanniman et al., 2006; LeBoeuf et al., 1994), high-fat diet (Hernández Vallejo et al., 2009), diabetes (Hanniman et al., 2006), and hepatic steatosis increase hepatic ApoA-IV expression through CREBH (Xu et al., 2014).